- January 2015 (12)
- December 2014 (2)
- November 2014 (2)
- September 2014 (4)
- June 2014 (7)
- May 2014 (6)
- March 2014 (1)
- March 2014 (1)
- February 2014 (9)
- January 2014 (7)
- December 2013 (4)
- November 2013 (5)
- September 2013 (14)
- June 2013 (15)
- May 2013 (7)
- April 2013 (19)
- March 2013 (21)
- March 2013 (47)
- February 2013 (19)
- January 2013 (17)
- December 2012 (10)
- November 2012 (12)
- September 2012 (8)
- August 2012 (17)
- July 2012 (16)
- June 2012 (14)
- May 2012 (15)
- April 2012 (9)
- March 2012 (4)
- March 2012 (5)
- February 2012 (4)
- - New section - (1)
- Completed Experiments (158)
- Experiments (174)
- MNR101-110 (13)
- MNR111-120 (13)
- MNR51-60 (3)
- MNR61-70 (1)
- MNR81-90 (4)
- MNR91-100 (5)
- mnr121-130 (7)
Orange semi-solid (323 mg, 1.47 mmol, 83% crude yield)
Procedure:
MNR 99-3 (300 mg, 1.76 mmol, 1 equiv.) was dissolved in N,N-dimethylethylenediamine (1.15 mL, 10.6 mmol, 6 equiv.) and stirred at 100 ˚C. AFter 1 h, no SM present on TLC although product couldn't be clearly seen either. Reaction mixture had turned from yellow solution to white/yellow cloudy mixture. Reaction was stopped and cooled to room temperature then partitioned between EtOAc and water. The aqueous phases were extracted with EtOAc (very cloudy white ppt started to form), then combined org. phases washed with brine, dried (MgSO4), filtered and evaporated to yield an orange oil.
AFter 1 h, no SM present on TLC although product couldn't be clearly seen either. Reaction mixture has turned from orange solution to white/yellow cloudy mixture. Reaction was stopped and cooled to room temperature then partitioned between EtOAc and water. The aqueous phases were extracted with EtOAc (insoluble white oil/solid started to crash out so all layers kept) then combined org. phases washed with brine, dried (MgSO4), filtered and evaporated to yield an orange oil, which slowly crystallised to an orange semi-solid (323 mg, 1.47 mmol, 83% crude yield) and used as crude in AEW 66-1. NMR shows impurity with similar signals to product - used without purification.
Data:
1H NMR (300 MHz, CDCl3) δ: 8.44 (1H, s), 7.62 (1H, d, J 5.7), 7.29 (1H, d, J 5.7), 3.83 (2H, t, J 6.7), 3.39 (3H, s), 2.84 (2H, t, J 6.7), 2.40 (3H, s), 2.19 (1H, s); 13C NMR (125 MHz, CDCl3) δ: 160.6, 158.3, 154.1, 131.4, 124.7, 114.0, 50.5, 49.6, 37.7, 36.3.
Hazard and Risk Assessment:
InChi:
InChI=1S/C6H3ClN2S/c7-6-5-4(1-2-10-5)8-3-9-6/h1-3H
and
InChI=1S/C4H12N2/c1-6(2)4-3-5/h3-5H2,1-2H3
to
InChI=1S/C10H14N4S/c1-14(2)5-4-11-10-9-8(3-6-15-9)12-7-13-10/h3,6-7H,4-5H2,1-2H3,(H,11,12,13)
Procedure:
MNR 99-3 (300 mg, 1.76 mmol, 1 equiv.) was stirred in ethanolamine (10% in water, 10.6 mL, 17.6 mmol, 10 equiv.) at 100 ˚C for 1 h.
AFter 1 h, no SM present on TLC although product couldn't be clearly seen either. Reaction mixture remains orange solution. Reaction was stopped and cooled to room temperature then partitioned between EtOAc and water. The aqueous phases were extracted with EtOAc then combined org. phases washed with brine, dried (MgSO4), filtered and evaporated to yield
Data:
Hazard and Risk Assessment:
InChi:
InChI=1S/C6H3ClN2S/c7-6-5-4(1-2-10-5)8-3-9-6/h1-3H
and
InChI=1S/C2H7NO/c3-1-2-4/h4H,1-3H2
to
InChI=1S/C8H9N3OS/c12-3-2-9-8-7-6(1-4-13-7)10-5-11-8/h1,4-5,12H,2-3H2,(H,9,10,11)
Reaction returned SM - mono-methyl derivative will be synthesised from MNR 99-3 and methyl amine prior to bromination
Starting material from Amination of chlorobromothienopyrimidine (AT-6-5)
Procedure:
A solution of acetic anhydride (49 microL, 0.52 mmol, 1.2 equiv.) in dry CH2Cl2 (0.5 mL) was added dropwise over 15 min to a stirred solution of AT 6-5 (100 mg, 0.43 mmol, 1.0 equiv.) and triethylamine (73 microL, 0.52 mmol, 1.2 equiv.) in dry CH2Cl2 (6.5 mL). After 15 minutes and then 1 h TLC analysis seemed to suggest no reaction but the SM and reaction mixture contained a streak to the main spot that is not present in the product spot. Decided to leave stirring o/n will check in the morning.
Volatiles removed in vacuo and the off white powder was sonicated and water and the cream solid filtered off to give 67 mg of SM.
Expected more product so: The aqueous layer was extracted with ethyl acetate, washed with water, brine, dried (MgSO4), filtered and evaporated to give starting material (20 mg).
Decided on alternative method for synthesis of mono-methylated analog.
Hazard and Risk Assessment:
Literature Ref:
http://intramural.nimh.nih.gov/mib/radio/pubs/radiopub2009-16.pdf
InChi
InChI=1S/C6H4BrN3S/c7-4-1-3-5(11-4)6(8)10-2-9-3/h1-2H,(H2,8,9,10)
to
InChI=1S/C8H6BrN3OS/c1-4(13)12-8-7-5(10-3-11-8)2-6(9)14-7/h2-3H,1H3,(H,10,11,12,13)
Repeat of Nucleophilic Displacement of MNR99 with 1-Methylpiperazine to give MNR125-1 but with 1.5 equiv of amine rather than 2.
Procedure:
To MNR 99-3 (1.0 g, 5.86 mmol, 1 equiv)) in THF (7 mL) (ethanol (5 mL added to get the starting material into solution) was added 1-methylpiperazine (0.98 mL, 8.79 mmol, 1.5 equiv) at 0 ˚C and the reaction mixture was stirred overnight at room temperature. Volatiles removed in vacuo (~4 mL remains) and then dissolved in EtOAc, washed with a saturated aqueous solution of sodium hydrogen carbonate, water, brine, dried (MgSO4), filtered and evaporated to give a
Data:
TLC 20 h 100% EtOAc
Hazard and Risk Assessment:
See Nucleophilic Displacement of MNR99 with 1-Methylpiperazine to give MNR125-1 and links within.
Starting material from commercially purchased 4-chloroethieno[3,2-d]pyrimidine
Repeat of Nucleophilic Displacement of MNR99 with ethyl 1-piperazinecarboxylate to give MNR126-1 but with 1.5 equiv of amine rather than 2.
Procedure
To 4-chloroethieno[3,2-d]pyrimidine (1.0 g, 5.86 mmol, 1 equiv) in THF (7 mL) (ethanol (5 mL added to get the starting material into solution) was added ethyl 1-piperazinecarboxylate (1.29 mL, 8.79 mmol, 1.5 equiv) at 0 ˚C. The reaction was stirred at room temperature overnight. Still some SM 20 h later. Stirred for the rest of the weekend. On Monday still SM but volatiles removed in vacuo (~4 mL remains) and then dissolved in EtOAc, washed with a saturated aqueous solution of sodium hydrogen carbonate, water, brine, dried (MgSO4), filtered and evaporated to give a cream solid (1.93g) containing ~1:<0.1 product:SM. Decided to column rather than use crude to avoid purification problems in the next step.
Hazard and Risk Assessment:
See Nucleophilic Displacement of MNR99 with ethyl 1-piperazinecarboxylate to give MNR126-1 and links contained within.
Data:
Crude 1H NMR
InChi
InChI=1S/C6H3ClN2S/c7-6-5-4(1-2-10-5)8-3-9-6/h1-3H
and
InChI=1S/C7H14N2O2/c1-2-11-7(10)9-5-3-8-4-6-9/h8H,2-6H2,1H3
to give
InChI=1S/C13H16N4O2S/c1-2-19-13(18)17-6-4-16(5-7-17)12-11-10(3-8-20-11)14-9-15-12/h3,8-9H,2,4-7H2,1H3